Rates of Clostridium difficile infection (CDI) have been on the rise in recent years and this diagnosis can result in significant costs for both individuals and the healthcare system as a whole. Given the recent updated guidelines for CDI, combined with several new agents emerging for this disease, it is critical for healthcare professionals to be aware of the most current research and recommendations for the management of CDI.
RMEI, LLC and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture titled "Clostridium difficile Infection: Emerging Therapies and Recurrence Prevention" which is certified for physicians, pharmacists and nurses. This activity is supported by an educational grant from Optimer.
Dale Gerding, MD, FACP, FIDSA, professor of medicine at the Stritch School of Medicine at Loyola University Chicago, will serve as moderator for this virtual lecture which was derived from a live symposium held in Boston in October 2011.
Healthcare professionals can visit http://www.rmei.com/ to access this activity.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.